nach oben

European Journal of Nuclear Medicine and Molecular Imaging

Erschienen in:

01.07.2005 | Controversies

FDG imaging should be considered the preferred technique for accurate assessment of myocardial viability

verfasst von: Jeroen J. Bax

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 7/2005

Einloggen, um Zugang zu erhalten

Excerpt

The number of patients presenting with heart failure has been increasing exponentially. It was recently estimated that 4.9 million patients in the United States have chronic heart failure, with 550,000 new cases per year, resulting in 970,000 hospitalisations [1]. The underlying aetiology of heart failure is frequently coronary artery disease; Gheorghiade and Bonow estimated that more than 70% of patients with heart failure have underlying coronary artery disease [2]. …

American Heart Association (2005) Heart disease and stroke statistics, 2005 update. American Heart Association

Gheorghiade M, Bonow RO. Chronic heart failure in the United States. A manifestation of coronary artery disease. Circulation 1998;97:282–9PubMed

Bax JJ, Van der Wall EE, Harbinson M. Radionuclide techniques for the assessment of myocardial viability and hibernation. Heart 2004;90 Suppl 5:v26–33CrossRefPubMed

Tillisch J, Brunken R, Marshall R, Schwaiger M, Mandelkern M, Phelps M, et al. Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. N Engl J Med 1986;314:884–8PubMed

Tamaki N, Yonekura Y, Yamashita K, Saji H, Magata Y, Senda M, et al. Positron emission tomography using fluorine-18 deoxyglucose in evaluation of coronary artery bypass grafting. Am J Cardiol 1989;64:860–5CrossRefPubMed

Bax JJ, Patton JA, Poldermans D, Elhendy A, Sandler MP. 18-Fluorodeoxyglucose imaging with PET and SPECT: cardiac applications. Semin Nucl Med 2000;30:281–98PubMed

Marwick TH, Nemec JJ, Lafont A, Salcedo EE, MacIntyre WJ. Prediction by postexercise fluoro-18 deoxyglucose positron emission tomography of improvement in exercise capacity after revascularization. Am J Cardiol 1992;69:854–9CrossRefPubMed

Di Carli MF, Asgarzadie F, Schelbert HR, Brunken RC, Laks H, Phelps ME, et al. Quantitative relation between myocardial viability and improvement in heart failure symptoms after revascularization in patients with ischemic cardiomyopathy. Circulation 1995;92:3436–44PubMed

Haas F, Augustin N, Holper K, Wottke M, Haehnel C, Nekolla S, et al. Time course and extent of improvement of dysfunctioning myocardium in patients with coronary artery disease and severely depressed left ventricular function after revascularization: correlation with positron emission tomographic findings. J Am Coll Cardiol 2000;36:1927–34CrossRefPubMed

10.

Di Carli M, Davidson M, Little R, Khanna S, Mody FV, Brunken RC, et al. Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction. Am J Cardiol 1994;73:527–33CrossRefPubMed

11.

Beanlands RSB, DeKemp R, Smith S, Johansen HL, Ruddy TD. F-18-fluorodeoxyglucose PET imaging alters clinical decision making in patients with impaired ventricular function. Am J Cardiol 1997;79:1092–5CrossRefPubMed

12.

Bax JJ, Poldermans D, Elhendy A, Boersma E, Rahimtoola SH. Sensitivity, specificity, and predictive accuracies of various noninvasive techniques for detecting hibernating myocardium. Curr Probl Cardiol 2001;26:142–86

13.

Pagano D, Townend JN, Parums DV, Bonser RS, Camici PG. Hibernating myocardium: morphological correlates of inotropic stimulation and glucose uptake. Heart 2000;83:456–61CrossRefPubMed

14.

Matsunari I, Boning G, Ziegler SI, Nekolla SG, Stollfuss JC, Kosa I, et al. Attenuation-corrected^99mTc-tetrofosmin single-photon emission computed tomography in the detection of viable myocardium: comparison with positron emission tomography using¹⁸F-fluorodeoxyglucose. J Am Coll Cardiol 1998;32:927–35CrossRefPubMed

15.

Bax JJ, Wijns W. Fluorodeoxyglucose imaging to assess myocardial viability: PET, SPECT or gamma camera coincidence imaging? J Nucl Med 1999;40:1893–5PubMed

Titel: FDG imaging should be considered the preferred technique for accurate assessment of myocardial viability
verfasst von: Jeroen J. Bax
Publikationsdatum: 01.07.2005
Verlag: Springer-Verlag
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 7/2005
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI: https://doi.org/10.1007/s00259-005-1826-8

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 7/2005

Prostate cancer: a comparative study of 11C-choline PET and MR imaging combined with proton MR spectroscopy

18F-FDG PET in malignant lymphoma: significance of positive findings

Biodistribution of radiolabelled human dendritic cells injected by various routes

Ernst Schering Research Foundation, Workshop 49

July 2005

Dosimetry of 60/61/62/64Cu-ATSM: a hypoxia imaging agent for PET